93 related articles for article (PubMed ID: 22079424)
1. The inhibitory potency of local anesthetics on NMDA receptor signalling depends on their structural features.
Gronwald C; Vegh V; Hollmann MW; Hahnenkamp A; Garaj V; Hahnenkamp K
Eur J Pharmacol; 2012 Jan; 674(1):13-9. PubMed ID: 22079424
[TBL] [Abstract][Full Text] [Related]
2. Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C.
Hahnenkamp K; Durieux ME; Hahnenkamp A; Schauerte SK; Hoenemann CW; Vegh V; Theilmeier G; Hollmann MW
Br J Anaesth; 2006 Jan; 96(1):77-87. PubMed ID: 16299047
[TBL] [Abstract][Full Text] [Related]
3. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics.
Solt K; Eger EI; Raines DE
Anesth Analg; 2006 May; 102(5):1407-11. PubMed ID: 16632818
[TBL] [Abstract][Full Text] [Related]
5. Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.
Kelly EW; Solt K; Raines DE
Anesth Analg; 2007 Nov; 105(5):1287-92, table of contents. PubMed ID: 17959956
[TBL] [Abstract][Full Text] [Related]
6. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
McBain CJ; Kleckner NW; Wyrick S; Dingledine R
Mol Pharmacol; 1989 Oct; 36(4):556-65. PubMed ID: 2554111
[TBL] [Abstract][Full Text] [Related]
8. The effects of the local anesthetics lidocaine and procaine on glycine and gamma-aminobutyric acid receptors expressed in Xenopus oocytes.
Hara K; Sata T
Anesth Analg; 2007 Jun; 104(6):1434-9, table of contents. PubMed ID: 17513637
[TBL] [Abstract][Full Text] [Related]
9. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Buller AL; Larson HC; Morrisett RA; Monaghan DT
Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
[TBL] [Abstract][Full Text] [Related]
10. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ethanol sensitivity of rat brain kainate, DL-alpha-amino-3-hydroxy-5-methyl-4-isoxalone proprionic acid and N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Dildy-Mayfield JE; Harris RA
J Pharmacol Exp Ther; 1992 Aug; 262(2):487-94. PubMed ID: 1380078
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
Curras MC; Dingledine R
Mol Pharmacol; 1992 Mar; 41(3):520-6. PubMed ID: 1372086
[TBL] [Abstract][Full Text] [Related]
13. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.
Askalany AR; Yamakura T; Petrenko AB; Kohno T; Sakimura K; Baba H
Neurosci Res; 2005 Aug; 52(4):387-92. PubMed ID: 15982768
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels.
Ahern CA; Eastwood AL; Dougherty DA; Horn R
Circ Res; 2008 Jan; 102(1):86-94. PubMed ID: 17967784
[TBL] [Abstract][Full Text] [Related]
16. The influence of calcium ions on nickel modulation of NMDA receptor currents.
Gavazzo P; Guida P; Marchetti C
Metallomics; 2011 Dec; 3(12):1376-83. PubMed ID: 22005730
[TBL] [Abstract][Full Text] [Related]
17. The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions.
Raines DE; Gioia F; Claycomb RJ; Stevens RJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):14-21. PubMed ID: 15166258
[TBL] [Abstract][Full Text] [Related]
18. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
Kleckner NW; Dingledine R
Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites.
Subramaniam S; Donevan SD; Rogawski MA
Mol Pharmacol; 1994 Jan; 45(1):117-24. PubMed ID: 8302270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
